A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma
Crossref DOI link: https://doi.org/10.1186/s12885-016-2800-5
Published Online: 2016-10-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Yiyu
Gu, Weiguang
Deng, Jin
Yang, Hua
Yang, Wen